Dr. Eric Adler
former Chief Medical Officer and Head of Research and an executive officer; co-founder of Stelios and a selling shareholder
Approximately $1.3 million
third quarter of 2024
Share of the milestone payment to the selling shareholders of Stelios under the July 16, 2021 acquisition of Stelios by the company.
With Stelios Therapeutics Inc.
Open in proxy